Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 337 - 344 of 12004 results

EnforceMintz — Novel Criminal Charges and Emerging Civil Trends from Opioid Enforcement in 2024

January 16, 2025| Blog| Viewpoint

EnforceMintz — Additional Health Care Provider Joins the OIG’s “Heightened Scrutiny” List in 2024

January 16, 2025| Blog| Viewpoint

EnforceMintz — Long Tail of Pandemic Fraud Schemes Will Likely Result in Continued Enforcement for Years to Come

January 16, 2025| Blog| Viewpoint

EnforceMintz — Telemedicine Enforcement: Trends in 2024 Suggest More Sophisticated Enforcement to Come in 2025

January 16, 2025| Blog| Viewpoint

EnforceMintz — 2024’s Key False Claims Act Settlements Involving Hospitals and Health Systems: Continued Focus on Stark Law and Anti-Kickback Statute Violations

January 16, 2025| Blog| Viewpoint

EnforceMintz — Don’t Forget Your Other Regulators: Consumer Protection Enforcement in Health Care Markets

January 16, 2025| Blog| Viewpoint

EnforceMintz — FCA Enforcement in Value-Based Care Arrangements Heated Up in 2024 and Likely to Remain a Priority in 2025

January 16, 2025| Blog| Viewpoint

EnforceMintz — Scienter, Causation, and Constitutional Questions: 2024’s Three Key FCA Litigation Issues

January 16, 2025| Blog| Viewpoint

News & Press Releases

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

Mintz Obtains Trademark TRO Against OpenAI on Behalf of IYO, Inc.

June 30, 2025

Mintz secured a rare trademark temporary restraining order (TRO) on behalf of IYO, Inc. against OpenAI, Sam Altman, Sir Jony Ive, and IO Products, Inc. The order temporarily bars the defendants from using the trademark associated with their new product launch.

Mintz Advises Brij in $8M Oversubscribed Funding Round

June 26, 2025

Mintz advised Brij—a software platform enhancing the consumer experience by bridging online and offline commerce—on the closing of its $8 million Series Seed round. The funding will help Brij advance its mission to close the trillion-dollar disconnect between brands and their retail customers and power the next generation of offline-to-online customer relationships.

View all News and Press Releases